RxMx was established in 2013 by a team of doctors focused on modernising and enhancing the effectiveness and safety of prescribing and monitoring specialty medicines.
RxMx offer agile technology solutions to monitor patient safety and automate risk management to seamlessly bring specialty drugs to market. The combination of a nursing team and user-friendly SaaS solutions is achieving industry leading voluntary enrolment rates for doctors and patient adherence rates of almost 100%.
RxMx is based in Sydney and has expanded with offices in New York and Berlin. It works with many of the top ten pharma companies around the world. RxMx has been profitable since launch, growing organically into new markets with its pharmaceutical clients and is currently operating in multiple countries.